OptiBiotix focused on expanding its roster of larger partners
The human microbiome-focused company is an expert in developing compounds to tackle obesity, cardiovascular disease and diabetes
Company
OptiBiotix Health PLC
LON:OPTI
OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing and commercialising technologies that modulate the human microbiome – the collective genome of the microbes in the body – the company identifies and develops prebiotic formulations and compounds for use in food ingredients and supplements that can impact on human physiology and metabolism, deriving potential health benefits.
574 stories · page 2 of 29
OptiBiotix Health enhances sports and well-being ranges
"The company has been working to develop new first-generation products like LeanBiome and WellBiome into the sports nutrition and health," Stephen O'Hara, OptiBiotix Health’s chief executive, said
OptiBiotix Health inks sweetener deal with a top ingredients company
It is teaming up with Switzerland's Firmenich to develop products and ingredients based on its SweetBiotix technology
OptiBiotix Health well-positioned to outperform with second-generation products
Cenkos's investment thesis is that OptiBiotix's share price represent fair value for its stakes in SkinBio and ProBiotix, with the underlying OptiBiotix business thrown in for free
Optibiotix Health boosts turnover after floating probiotic division
Cenkos advised investors to 'buy' the stock, saying growth is supported by commercial agreements with large partners and a substantial pipeline of opportunities
OptiBiotix Health demerger complete as ProBiotix Health debuts on Aquis exchange
The focus of the newly-independent business is human microbiome-modulating compounds that tackle cardiovascular disease and other lifestyle conditions
OptiBiotix Health plans separate Aquis listing for ProBiotix Health arm
OptiBiotix shareholders will receive a distribution in specie of ProBiotix shares once the float is completed at the end of this month
OptiBiotix Health makes three key hires as it continues its commercial push
Zac Sniderman is taking on the role of business development and sales director in North America, Shiraz Butt is to be the company’s e-commerce director and Karl Burkitt the marketing director
OptiBiotix continues to grow profits on back of sales push
Gross profit up 36% last year to £1.2mln as prebiotic and probiotic businesses add commercial agreements
Does the Gartner Hype Cycle explain the ebb and flow of the multi-billion dollar human microbiome industry?
In equity research, the hypecycle is used to describe the movement of markets and sectors as well as individual stock
OptiBiotix Health sets out blue-print for next growth phase; hails potential of three key deals
Chief executive Stephen O'Hara and his team provided a comprehensive strategic over of the business progress and plans
OptiBiotix Health says consumer study shows CholBiome effective in reducing cholesterol
The life sciences company said 96% of consumers taking CholBiomeX3 reported a reduction in their total cholesterol levels
OptiBiotix Health: Building on its commercial momentum with a second-generation of microbiome-focused products
OptiBiotix is a pioneer of probiotics and prebiotics that work synergistically with the human microbiome, the ecosystem of bacteria found largely in the gut. Its discoveries have been or are being developed to tackle obesity, cardiovascular
OptiBiotix Health says latest study supports case for LPLDL as an alternative to statins
After six weeks, the study indicated a 28.4% reduction in so-called bad cholesterol.
OptiBiotix Health achieves UK accreditation
The accreditation "supports our commercial strategy of selling final product solutions to partners in the retail channel containing our science-backed pro and prebiotic ingredients," said CEO René Kamminga
OptiBiotix Health inks exclusive deal to supply weight management range to Saudi Arabia's largest pharmacy chain
A store launch of an initial seven products from the OptiBiotix range is planned for the first half of next year
Small Cap Wrap - Altus Strategies, OptiBiotix, Angle and more...
The mining royalty Company generating a diversified and precious metal focused portfolio of assets announces that reverse circulation (RC) drilling has extended the strike length of the FT Prospect by at least 150m, to beyond 3km at the Tab
OptiBiotix expands team with two new appointments
The company said it has appointed Christopher Nother as a part time consultant to support the growth of its LPLDL product, while it has also recruited Taru Jain to its management team to focus on growing sales in Asia
OptiBiotix Health inks agreement to jointly fund and carry out a research project involving its microbiome products
The agreement is with Fondazione Edmund Mach - Centro Ricerca e Innovazione, based in Trento, Italy, and the University of Southampton
OptiBiotix Health says it intends to appoint experienced pharma executive, Christopher Brinsmead as a non-executive director
Brinsmead has worked in the pharmaceutical industry for over 30 years, holding executive leadership roles with ICI, and Zeneca, before becoming chairman of AstraZeneca Pharmaceuticals UK, President of AstraZeneca UK and Ireland